Who are LEAH Labs's investors?

LEAH Labs's investors include GROOVE CAPITAL, Southeast Minnesota Capital Fund, Y Combinator, Ag Startup Engine Seed, Wefunder.

Where is LEAH Labs headquartered?

LEAH Labs is headquartered in Minneapolis, US.

LEAH Labs

YC W19

Minneapolis, US · Founded 2018 · 4 employees · 5 known investors

Find your way into LEAH Labs

Paths you didn't know you had: your email and LinkedIn already hold routes to the LEAH Labs team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

LEAH Labs engineers gene-edited CAR-T cell therapies to treat cancer in pet dogs, with the goal of generating translational insights for human cancer therapy. The company uses proprietary gene editing and protein design to develop therapeutic treatments for companion animal oncology.

Also known as LifEngine Animal Health Laboratories Incorporated · Incorporated · Lifengine Animal Health Laboratories · Lifengine Animal Health Laboratories, Incorporated

AI & Machine Learning Biotech Healthtech Medical Devices CRISPR Cell Therapy Drug discoveryUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W19)

Wesley Wierson FounderWesley Wierson is a scientist and entrepreneur with expertise in gene editing who founded LEAH Labs to develop cancer therapies using CAR-T technology in veterinary settings, which he identified as a pathway to market with lighter regulatory requirements than human therapeutics.

Stephen C. EkkerScientific Founder & Board Director

Saad S. KenderianScientific Founder

Jonathan P. MochelScientific Founder

Saad S. Kenderian, MB/ChBScientific Founder

Jonathan P. Mochel, PhD/DECVPTScientific Founder

Alex M. Abel Chief Scientific OfficerAlex M. Abel is Chief Scientific Officer of LEAH Labs, which develops gene-edited CAR-T cell therapies for canine cancer treatment using proprietary gene editing and protein design techniques.

Zachary WareJoncas

Investors · 5

GROOVE CAPITALlisted by GROOVE CAPITALMinneapolis

How we know: GROOVE CAPITAL's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Southeast Minnesota Capital Fundlisted by Southeast Minnesota Capital FundRochester

How we know: Southeast Minnesota Capital Fund's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Ag Startup Engine SeedreportedAmes

How we know: Y Combinator's founder network · Not right? Tell us

WefunderreportedSan Francisco

How we know: press coverage · Y Combinator's founder network · Not right? Tell us

Related companies · 7

Unchained LabsUnchained Labs builds instruments for lipid nanoparticle and other nanomedicine production, spanning R&D formulation screening through GMP-compliant clinical manufacturing. Its Sunny Suite uses a consistent mixing process to help pharmaceutical and biotech developers transfer nanoparticle production from lab scale to liter-scale GMP output.

Algen BiotechnologiesAlgen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.

SteamcommunitySteam Community is the online hub and social platform for Steam, the PC gaming distribution service operated by Valve, where players discuss games, share content, and connect with other users.

NephrogenNephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.

Leash BioLeash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.

Uncommon TherapeuticsUncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.

Indee LabsIndee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing. The platform enables rapid production of high-quality T-cell immunotherapies and other cell therapies with preserved cell function.

Companies working in the same space as LEAH Labs.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Science Foundation	Phase II	2023	$973.9K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2022	$337.4K
National Science Foundation	Phase I	2020	$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 1

corporate structure

LifEngine Animal Health Laboratories Incorporated

In the news

LEAH Labs Raises $3 Million in Funding for Groundbreaking Pet Therapiesleadsontrees.com · Sep 2024

Frequently asked questions

What does LEAH Labs do?: LEAH Labs engineers gene-edited CAR-T cell therapies to treat cancer in pet dogs, with the goal of generating translational insights for human cancer therapy. The company uses proprietary gene editing and protein design to develop therapeutic treatments for companion animal oncology.
Who founded LEAH Labs?: LEAH Labs was founded by Wesley Wierson, Stephen C. Ekker, Saad S. Kenderian, Jonathan P. Mochel, Saad S. Kenderian, MB/ChB, Jonathan P. Mochel, PhD/DECVPT in 2018.
Who are LEAH Labs's investors?: LEAH Labs's investors include GROOVE CAPITAL, Southeast Minnesota Capital Fund, Y Combinator, Ag Startup Engine Seed, Wefunder.
Where is LEAH Labs headquartered?: LEAH Labs is headquartered in Minneapolis, US.